Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|6|430-439

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.6, 2015-06, pp. : 430-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 761-768

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic polymorphisms in the microRNA binding‐sites of the thymidylate synthase gene predict risk and survival in gastric cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 880-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic induction of tissue inhibitor of matrix metalloproteinase‐3 by green tea polyphenols in breast cancer cells

By  

Molecular Carcinogenesis, Vol. 54, Iss. 6, 2015-06 ,pp. : 485-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 462-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 216-224

John Wiley & Sons Inc

Access to resources Recommend Favorite